Evidence map›Paper›PMID 40661959›Full record

ArticleFrontiers in immunology2025

Single-cell RNA-sequencing highlights a curtailed NK cell function in convalescent COVID-19 pregnant women.

Madhuri S Salker, Nor Haslinda Abd Aziz, Natalia Carman Prodan, Zhiqi Yang, Aditya Kumar Lankapalli, Katrin Lazar, Mohamad Nasir Shafiee, Ersoy Kocak, Harivignesh Ganesan, Surya Sekhar Pal and 14 more

Abstract read
In one paragraph

Article in Frontiers in immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors.

Madhuri S Salker *Department of Women's Health, Research Institute for Women's Health, University of Tübingen, Tübingen, Germany.
Nor Haslinda Abd Aziz *Department of Obstetrics and Gynaecology, Faculty of Medicine, Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia.
Natalia Carman ProdanDepartment of Women's Health, Research Institute for Women's Health, University of Tübingen, Tübingen, Germany.
Zhiqi YangDepartment of Women's Health, Research Institute for Women's Health, University of Tübingen, Tübingen, Germany.
Aditya Kumar LankapalliDepartment of Biology, Ineos Oxford Institute of Antimicrobial Research, University of Oxford, Oxford, United Kingdom.
Katrin LazarIntitute for Medical Virology and Epidemiology of Viral Diseases, University Hospital Tübingen, Tübingen, Germany.
Mohamad Nasir ShafieeDepartment of Obstetrics and Gynaecology, Faculty of Medicine, Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia.
Ersoy KocakInstitute of Medical Genetics and Applied Genomics, University of Tübingen, Tübingen, Germany.
Harivignesh GanesanInstitute of Medical Genetics and Applied Genomics, University of Tübingen, Tübingen, Germany.
Surya Sekhar PalDepartment of Women's Health, Research Institute for Women's Health, University of Tübingen, Tübingen, Germany.
Omer KhalidDepartment of Women's Health, Research Institute for Women's Health, University of Tübingen, Tübingen, Germany.
Norhana Mohd KasimDepartment of Obstetrics and Gynaecology, Sungai Buloh Hospital, Selangor, Malaysia.
Aida KalokDepartment of Obstetrics and Gynaecology, Faculty of Medicine, Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia.
Norashikin Abdul FuadDepartment of Obstetrics and Gynaecology, Sungai Buloh Hospital, Selangor, Malaysia.
Alfred Lennart BissingerIntitute for Medical Virology and Epidemiology of Viral Diseases, University Hospital Tübingen, Tübingen, Germany.
Tina GanzenmuellerIntitute for Medical Virology and Epidemiology of Viral Diseases, University Hospital Tübingen, Tübingen, Germany.
Thomas IftnerIntitute for Medical Virology and Epidemiology of Viral Diseases, University Hospital Tübingen, Tübingen, Germany.
Karl Oliver KaganDepartment of Women's Health, Research Institute for Women's Health, University of Tübingen, Tübingen, Germany.
Stephan OssowskiInstitute of Medical Genetics and Applied Genomics, University of Tübingen, Tübingen, Germany.
Nicolas CasadeiInstitute of Medical Genetics and Applied Genomics, University of Tübingen, Tübingen, Germany.
Sara Y BruckerDepartment of Women's Health, Research Institute for Women's Health, University of Tübingen, Tübingen, Germany.
Olaf RiessInstitute of Medical Genetics and Applied Genomics, University of Tübingen, Tübingen, Germany.
Yogesh SinghDepartment of Women's Health, Research Institute for Women's Health, University of Tübingen, Tübingen, Germany.
Deutsche COVID-19 OMICS Initiative (DeCOI)

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: During gestation the immune system undergoes dramatic remodelling to protect the maternal-fetal dyad from infections whilst also preventing fetal rejection. We investigated how SARS-CoV-2 modifies the immune landscape during infection and in recovered pregnant women. Methods: We immunophenotyped our two independent geographical cohorts using a 14-colour flow cytometry panel (surface and intracellular staining). We estimated cytokines and SARS-CoV-2 IgG antibodies in validation cohort using a multiplexd flow cytometry panel. Single-cell RNA sequencing (scRNA-seq) was performed using a Chromium Single Cell 3' Gel Bead Chip and Library Kit from 10x Genomics (Drop-seq method). Furthermore, we estimated the cytotoxic functions of natural killer (NK) cells by flow cytometry using surface and intracellular staining. Results: Using two independent geographical cohorts, we identified that NK cells had a sustained reduction during active infection and after recovery. Further, scRNA-seq data revealed that infection with SARS-CoV-2 rewired the gene expression profile of NK, monocytes, CD4 Discussion: Overall, our study uncovers that SARS-CoV-2 infection deranges the adaptive immune response in pregnant women even after recovery and may contribute to post-COVID19 sequalae of symptoms.

Indexed as

COVID-19Killer Cells, NaturalPregnancy Complications, InfectiousSARS-CoV-2AdultAntibodies, ViralConvalescenceCytokinesFemaleHumansPregnancyRNA-SeqSequence Analysis, RNASingle-Cell AnalysisAntibodies, ViralCytokinesCOVID-19cytotoxic cellsimmunophenotyping and cytokinesNK cellsPBMCspregnancyScRNA-seq

Identifiers

PMID40661959
PMCPMC12257036

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.